Colgate Palmolive (CL)

Colgate Palmolive (CL) is currently regarded by experts as an attractive buy, particularly at its 52-week lows, where investors can also benefit from a 2.5% dividend yield. Despite facing challenges in the consumer staples sector, CL has demonstrated resilience by beating both top and bottom line expectations. Additionally, the company's supply chain issues are on the mend, although they still contend with tariff-related costs that were estimated at $200 million but have since been lowered to $75 million. Overall, the sentiment around CL remains positive, indicating that the company is well-positioned for recovery moving forward.